Invitae Corp
Change company Symbol lookup
Select an option...
NVTA Invitae Corp
KVHI KVH Industries Inc
BAC Bank of America Corp
BHC Bausch Health Companies Inc
ANPC AnPac Bio-Medical Science Co Ltd
TREX Trex Company Inc
VIVO Meridian Bioscience Inc
WASH Washington Trust Bancorp Inc
AWF AllianceBernstein Global High Income Fund Inc.
AVK Advent Convertible & Income Fund
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.

Price
Delayed
$45.90
Day's Change
0.64 (1.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
45.96
Day's Low
44.68
Volume
(Light)

Today's volume of 44,460 shares is on pace to be much lighter than NVTA's 10-day average volume of 2,659,962 shares.

44,460

Upcoming Events

NVTA's fiscal year ends in December
There are no upcoming events for NVTA

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
August 4, 2020Q2 2020 Earnings Release-$1.29-$0.89 to -$0.43-$0.52
May 5, 2020Q1 2020 Earnings Release-$1.03-$0.901 to -$0.73-$0.47
February 19, 2020Q4 2019 Earnings Release-$0.63-$0.85 to -$0.44-$0.40
November 6, 2019Q3 2019 Earnings Release-$0.69-$0.91 to -$0.43-$0.45

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.